While Moderna Inc. plans to cut its expenses by $1 billion in 2025, the company has received a little breathing room by a hefty U.S. Department of Health and Human Services (HHS) grant. The Biomedical ...
The study included vaccine candidates against H5 and H7 avianinfluenza viruses. Based on the positive preliminary data from the Phase 1/2 study, Moderna is preparing to advance mRNA-1018 into ...
The escalating bird flu crisis is ravaging the nation's supply of eggs, leading to increased prices and presenting an immediate challenge for the Trump administration. Why it matters: An outbreak of ...